PALO ALTO, Calif.--(BUSINESS WIRE)--Science Exchange, the leading SaaS-enabled marketplace platform for outsourced R&D services, recently presented at the invitation-only Piper Sandler Healthcare Conference held December 1-3, 2020.
Thousands of select leaders from the pharmaceutical and biotechnology industry, including investors, CEOs, CFOs, and market analysts attended the presentation, delivered by Elizabeth Iorns, Ph.D., CEO and Co-Founder of Science Exchange. In the presentation, titled “Developing the R&D Model of the Future: A Platform Approach for Outsourced R&D,” Dr. Iorns described how leveraging a networked, platform approach for outsourcing can reverse the decline in R&D productivity that the industry is facing.
"Elizabeth's presentation was met with exceptionally positive feedback from the investor community across both public and private markets,” said Shaun O’Connor, VP and Head of Corporate Development at Science Exchange. “It reaffirmed our position as an innovator and market leader as well as the belief in our strategy and approach to transforming R&D and creating value for our partners."
View a 30-second excerpt of the presentation here; for the full recording, visit Piper Sandler’s event portal.
About Science Exchange
Science Exchange enables scientists to catalyze faster discovery and development by removing barriers from the outsourced R&D workflow. We are passionate about building transformative software solutions that help accelerate discovery and that ultimately improve lives. The Science Exchange stack of solutions improves R&D speed, innovation, flexibility, and auditability. Our source-to-pay tools boost scientists' productivity by removing administrative tasks and delays associated with sourcing, establishing and managing projects with external service providers. With our enterprise SaaS-enabled marketplace product, R&D teams can rapidly work with the Science Exchange Contracted™ network of 3,300 CROs, CMOs, and academic labs, without the need for CDAs, MTAs or other time-consuming legal documents. Our clients include some of the world’s largest biopharmas and hundreds of biotechs, who have been increasing productivity through simple and lean outsourcing processes.
Since 2011, Science Exchange has raised more than $70 million from Norwest Venture Partners, Maverick Ventures, Union Square Ventures, Collaborative Fund, Windham Ventures, OATV, the YC Continuity Fund, and others.
Learn why life science leaders rave about how Science Exchange is transforming discovery and development at www.scienceexchange.com. Connect with us on LinkedIn and on Twitter.
